Correlation Between Aerovate Therapeutics and Yakult Honsha

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Yakult Honsha at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Yakult Honsha into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Yakult Honsha Co, you can compare the effects of market volatilities on Aerovate Therapeutics and Yakult Honsha and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Yakult Honsha. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Yakult Honsha.

Diversification Opportunities for Aerovate Therapeutics and Yakult Honsha

-0.66
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Aerovate and Yakult is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Yakult Honsha Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Yakult Honsha and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Yakult Honsha. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Yakult Honsha has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Yakult Honsha go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Yakult Honsha

Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the Yakult Honsha. In addition to that, Aerovate Therapeutics is 2.12 times more volatile than Yakult Honsha Co. It trades about -0.03 of its total potential returns per unit of risk. Yakult Honsha Co is currently generating about 0.05 per unit of volatility. If you would invest  878.00  in Yakult Honsha Co on September 12, 2024 and sell it today you would earn a total of  162.00  from holding Yakult Honsha Co or generate 18.45% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Aerovate Therapeutics  vs.  Yakult Honsha Co

 Performance 
       Timeline  
Aerovate Therapeutics 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Yakult Honsha 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Yakult Honsha Co are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Yakult Honsha may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Aerovate Therapeutics and Yakult Honsha Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aerovate Therapeutics and Yakult Honsha

The main advantage of trading using opposite Aerovate Therapeutics and Yakult Honsha positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Yakult Honsha can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Yakult Honsha will offset losses from the drop in Yakult Honsha's long position.
The idea behind Aerovate Therapeutics and Yakult Honsha Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Stocks Directory
Find actively traded stocks across global markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios